FMC Corporation (FMC)
FMC's Tremisia Fungicide Debuts in EMEA Region After Approvals
FMC launches Tremisia fungicide in Ukraine, bringing fluindapyr tech to EMEA growers battling major crop diseases.
Hold On To FMC Corporation (Rating Downgrade)
We assess FMC Corporation as a Hold to moderate buy, downgrading from a previous buy opportunity due to weak growth, momentum, and financial potential. FMC's strengths are its innovation, R&D focus, and attractive 5.4% dividend yield, but revenue and profit have declined for several years. FMC valuation is fair around $50 per share, but insider and hedge fund selling, high debt, and weak near-term growth limit upside.
FMC and Corteva Partner to Expand Access to Fluindapyr Fungicide
FMC teams up with Corteva to expand fluindapyr fungicide access, targeting key U.S. corn and soybean markets.
Why Is FMC (FMC) Up 2.3% Since Last Earnings Report?
FMC (FMC) reported earnings 30 days ago. What's next for the stock?
FMC Corporation Could Become One Of The Best Turnaround Play Of 2025
FMC has suffered a 70% stock decline due to lower sales, destocking, and a slashed 2025 forecast, but offers turnaround potential. The company's diverse segments and new product pipeline position it to benefit from rising global food demand and sustainability trends. Valuation is attractive with a low P/E and P/B, but growth remains the key challenge as FMC transitions from legacy products to new launches.
FMC Corporation: A Look At The Forces Undermining Its Success
FMC Corporation specializes in insecticides, herbicides, crop nutrition, and pest control for both agricultural and non-agricultural markets. Despite a diverse product portfolio, FMC has delivered a disappointing -3.5% total return over the past decade. The company hasn't raised its dividend for a few years, and a dividend cut is possible.
Why FMC (FMC) International Revenue Trends Deserve Your Attention
Examine FMC's (FMC) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
FMC Corporation (FMC) Q1 2025 Earnings Conference Call Transcript
FMC Corporation (NYSE:FMC ) Q1 2025 Earnings Conference Call May 1, 2025 9:00 AM ET Company Participants Curt Brooks - Director of IR Pierre Brondeau - Chairman and CEO Andrew Sandifer - EVP and CFO Ronaldo Pereira - President Conference Call Participants Aleksey Yefremov - KeyBanc Joel Jackson - BMO Capital Edgar Rodriguez - Mizuho Daniel Rizzo - Jefferies Chris Parkinson - Wolfe Research Benjamin Theurer - Barclays Patrick Cunningham - Citigroup Vincent Andrews - Morgan Stanley Lucas Beaumont - UBS Frank Mitsch - Fermium Research Operator Good morning and welcome to the First Quarter 2025 Earnings Call for the FMC Corporation. This event is being recorded.
FMC Corp's Earnings and Revenues Surpass Estimates in Q1
Lower prices, mostly due to price adjustments in certain contracts, hurt FMC's Q1 sales.
FMC (FMC) Tops Q1 Earnings and Revenue Estimates
FMC (FMC) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.36 per share a year ago.
FMC to Report Q1 Earnings: What's in the Cards for the Stock?
FMC's cost actions and new product launches are expected to have contributed to its performance amid headwinds from de-stocking in Q1.
FMC (FMC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
FMC (FMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
